MedTrace Logo

The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor

NCT07181070 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-09-23

No results posted yet for this study

Summary

The aim this prospective observational study is to evaluate the role of Indocyanine Green Fluorescence (ICG) in patients with achalasia underwent to Heller-Dor laparoscopic. The main gol are:

* If with use of ICG iatrogenic mucosal leaks can be identified and, if necessary, improve the myotomy.
* Assess the need for postoperative radiographic control using esophagogastric radiography with gastrografin.
* Compare clinical characteristics, perioperative outcomes, and 12-month postoperative follow-up between the two populations.

Conditions

  • Achalasia, Esophageal
  • Achalasia
  • Indocyanine Green (ICG)
  • Indocyanine Green

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Principal Investigators

  • Giovanni Aprea, Prof. · Federico II University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2025-10-31
Completion
2026-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07181070 on ClinicalTrials.gov